Multi-label classification of Alzheimer's disease stages from resting-state fMRI-based correlation connectivity data and deep learning

Alzheimer's disease is a neurodegenerative condition that gradually impairs cognitive abilities. Recently, various neuroimaging modalities and machine learning methods have surfaced to diagnose Alzheimer's disease. Resting-state fMRI is a neuroimaging modality that has been widely utilized to study brain activity related to neurodegenerative diseases. In literature, the previous studies are limited to the binary classification of Alzheimer's disease and Mild Cognitive Impairment. The application of computer-aided diagnosis for the numerous advancing phases of Alzheimer's disease, on the other hand, remains understudied. This research analyzes and presents methods for multi-label classification of six Alzheimer's stages using rs-fMRI and deep learning. The proposed model solves the multi-class classification problem by extracting the brain's functional connectivity networks from rs-fMRI data and employing two deep learning approaches, Stacked Sparse Autoencoder and Brain Connectivity Graph Convolutional Network. The suggested models' results were assessed using the k-fold cross-validation approach, and an average accuracy of 77.13% and 84.03% was reached for multi-label classification using Stacked Sparse Autoencoders and Brain Connectivity Based Convolutional Network, respectively. An analysis of brain regions was also performed by using the network's learned weights, leading to the conclusion that the precentral gyrus, frontal gyrus, lingual gyrus, and supplementary motor area are the significant brain regions of interest.

A Deep Learning Approach for Automated Diagnosis and Multi-Class Classification of Alzheimer's Disease Stages Using Resting-State fMRI and Residual Neural Networks

Alzheimer's disease (AD) is an incurable neurodegenerative disorder accounting for 70%-80% dementia cases worldwide. Although, research on AD has increased in recent years, however, the complexity associated with brain structure and functions makes the early diagnosis of this disease a challenging task. Resting-state functional magnetic resonance imaging (rs-fMRI) is a neuroimaging technology that has been widely used to study the pathogenesis of neurodegenerative diseases. In literature, the computer-aided diagnosis of AD is limited to binary classification or diagnosis of AD and MCI stages. However, its applicability to diagnose multiple progressive stages of AD is relatively under-studied. This study explores the effectiveness of rs-fMRI for multi-class classification of AD and its associated stages including CN, SMC, EMCI, MCI, LMCI, and AD. A longitudinal cohort of resting-state fMRI of 138 subjects (25 CN, 25 SMC, 25 EMCI, 25 LMCI, 13 MCI, and 25 AD) from Alzheimer's Disease Neuroimaging Initiative (ADNI) is studied. To provide a better insight into deep learning approaches and their applications to AD classification, we investigate ResNet-18 architecture in detail. We consider the training of the network from scratch by using single-channel input as well as performed transfer learning with and without fine-tuning using an extended network architecture. We experimented with residual neural networks to perform AD classification task and compared it with former research in this domain. The performance of the models is evaluated using precision, recall, f1-measure, AUC and ROC curves. We found that our networks were able to significantly classify the subjects. We achieved improved results with our fine-tuned model for all the AD stages with an accuracy of 100%, 96.85%, 97.38%, 97.43%, 97.40% and 98.01% for CN, SMC, EMCI, LMCI, MCI, and AD respectively. However, in terms of overall performance, we achieved state-of-the-art results with an average accuracy of 97.92% and 97.88% for off-the-shelf and fine-tuned models respectively. The Analysis of results indicate that classification and prediction of neurodegenerative brain disorders such as AD using functional magnetic resonance imaging and advanced deep learning methods is promising for clinical decision making and have the potential to assist in early diagnosis of AD and its associated stages.